WLKP
WLKP
Westlake Chemical Partners LPIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $323.05M ▲ | $7.05M ▼ | $84.26M ▲ | 26.08% ▲ | $2.39 ▲ | $124.51M ▲ |
| Q3-2025 | $308.9M ▲ | $7.44M ▲ | $14.65M ▲ | 4.74% ▼ | $0.42 ▲ | $114.17M ▲ |
| Q2-2025 | $297.12M ▲ | $6.3M ▼ | $14.56M ▲ | 4.9% ▲ | $0.41 ▲ | $107.26M ▲ |
| Q1-2025 | $237.63M ▼ | $7.47M ▲ | $4.95M ▼ | 2.08% ▼ | $0.14 ▼ | $46.61M ▼ |
| Q4-2024 | $290.06M | $6.56M | $15M | 5.17% | $0.43 | $120.84M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $44.27M ▲ | $1.26B ▼ | $454.18M ▼ | $501.11M ▼ |
| Q3-2025 | $37.94M ▲ | $1.27B ▼ | $458.3M ▼ | $503.18M ▼ |
| Q2-2025 | $36.58M ▼ | $1.31B ▼ | $476.02M ▼ | $504.99M ▼ |
| Q1-2025 | $49.62M ▼ | $1.37B ▲ | $568.25M ▲ | $507.04M ▼ |
| Q4-2024 | $58.32M | $1.29B | $458.64M | $518.7M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $84.26M ▼ | $120.38M ▲ | $-18.83M ▼ | $-95.22M ▲ | $6.33M ▲ | $111.55M ▲ |
| Q3-2025 | $86.21M ▲ | $105.24M ▲ | $348K ▼ | $-104.23M ▼ | $1.36M ▲ | $75.59M ▲ |
| Q2-2025 | $85.8M ▲ | $9.07M ▼ | $35.62M ▲ | $-57.74M ▲ | $-13.04M ▼ | $-15.31M ▼ |
| Q1-2025 | $42.31M ▼ | $45.78M ▼ | $14.04M ▲ | $-68.52M ▲ | $-8.69M ▼ | $29.82M ▼ |
| Q4-2024 | $87.39M | $132.47M | $-38.47M | $-95.89M | $-1.89M | $119M |
Revenue by Products
| Product | Q3-2020 | Q4-2020 | Q1-2021 | Q2-2021 |
|---|---|---|---|---|
Product and Service Other | $10.00M ▲ | $20.00M ▲ | $50.00M ▲ | $80.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Westlake Chemical Partners LP's financial evolution and strategic trajectory over the past five years.
Key strengths include very strong profitability and cash generation, supported by a fee‑based, take‑or‑pay contract that smooths earnings and limits exposure to commodity price swings. The balance sheet is conservative with no reported debt and a net cash position, providing resilience and flexibility. The partnership also benefits from being a critical, integrated supplier within a larger petrochemical value chain, with tangible, productive assets and a history of stable distributions to unitholders.
The most significant risks relate to concentration and contract dependence: a single major customer and the ethylene sales agreement largely determine demand and margins, especially beyond the current contract horizon. Limited diversification, minimal reported investment in traditional R&D, and reliance on external financing or the parent for larger growth projects could constrain long‑term expansion. Regulatory and environmental pressures on petrochemicals, as well as the potential for plant outages or less favorable contract renewals, add further uncertainty.
Near‑term prospects appear relatively stable, with strong current margins, a debt‑free balance sheet, robust free cash flow, and no major planned turnarounds expected to disrupt operations. The medium‑ to long‑term outlook will hinge on how ethylene sales agreements are renewed or revised after their current term, how effectively WLKP executes its incremental growth levers, and how broader petrochemical demand and regulation evolve. Overall, WLKP looks positioned as a steady, infrastructure‑like cash generator, with its future shaped more by contract and capital allocation decisions than by rapid market growth or technological disruption.
About Westlake Chemical Partners LP
https://www.wlkpartners.comWestlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $323.05M ▲ | $7.05M ▼ | $84.26M ▲ | 26.08% ▲ | $2.39 ▲ | $124.51M ▲ |
| Q3-2025 | $308.9M ▲ | $7.44M ▲ | $14.65M ▲ | 4.74% ▼ | $0.42 ▲ | $114.17M ▲ |
| Q2-2025 | $297.12M ▲ | $6.3M ▼ | $14.56M ▲ | 4.9% ▲ | $0.41 ▲ | $107.26M ▲ |
| Q1-2025 | $237.63M ▼ | $7.47M ▲ | $4.95M ▼ | 2.08% ▼ | $0.14 ▼ | $46.61M ▼ |
| Q4-2024 | $290.06M | $6.56M | $15M | 5.17% | $0.43 | $120.84M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $44.27M ▲ | $1.26B ▼ | $454.18M ▼ | $501.11M ▼ |
| Q3-2025 | $37.94M ▲ | $1.27B ▼ | $458.3M ▼ | $503.18M ▼ |
| Q2-2025 | $36.58M ▼ | $1.31B ▼ | $476.02M ▼ | $504.99M ▼ |
| Q1-2025 | $49.62M ▼ | $1.37B ▲ | $568.25M ▲ | $507.04M ▼ |
| Q4-2024 | $58.32M | $1.29B | $458.64M | $518.7M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $84.26M ▼ | $120.38M ▲ | $-18.83M ▼ | $-95.22M ▲ | $6.33M ▲ | $111.55M ▲ |
| Q3-2025 | $86.21M ▲ | $105.24M ▲ | $348K ▼ | $-104.23M ▼ | $1.36M ▲ | $75.59M ▲ |
| Q2-2025 | $85.8M ▲ | $9.07M ▼ | $35.62M ▲ | $-57.74M ▲ | $-13.04M ▼ | $-15.31M ▼ |
| Q1-2025 | $42.31M ▼ | $45.78M ▼ | $14.04M ▲ | $-68.52M ▲ | $-8.69M ▼ | $29.82M ▼ |
| Q4-2024 | $87.39M | $132.47M | $-38.47M | $-95.89M | $-1.89M | $119M |
Revenue by Products
| Product | Q3-2020 | Q4-2020 | Q1-2021 | Q2-2021 |
|---|---|---|---|---|
Product and Service Other | $10.00M ▲ | $20.00M ▲ | $50.00M ▲ | $80.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Westlake Chemical Partners LP's financial evolution and strategic trajectory over the past five years.
Key strengths include very strong profitability and cash generation, supported by a fee‑based, take‑or‑pay contract that smooths earnings and limits exposure to commodity price swings. The balance sheet is conservative with no reported debt and a net cash position, providing resilience and flexibility. The partnership also benefits from being a critical, integrated supplier within a larger petrochemical value chain, with tangible, productive assets and a history of stable distributions to unitholders.
The most significant risks relate to concentration and contract dependence: a single major customer and the ethylene sales agreement largely determine demand and margins, especially beyond the current contract horizon. Limited diversification, minimal reported investment in traditional R&D, and reliance on external financing or the parent for larger growth projects could constrain long‑term expansion. Regulatory and environmental pressures on petrochemicals, as well as the potential for plant outages or less favorable contract renewals, add further uncertainty.
Near‑term prospects appear relatively stable, with strong current margins, a debt‑free balance sheet, robust free cash flow, and no major planned turnarounds expected to disrupt operations. The medium‑ to long‑term outlook will hinge on how ethylene sales agreements are renewed or revised after their current term, how effectively WLKP executes its incremental growth levers, and how broader petrochemical demand and regulation evolve. Overall, WLKP looks positioned as a steady, infrastructure‑like cash generator, with its future shaped more by contract and capital allocation decisions than by rapid market growth or technological disruption.

CEO
Jean-Marc Gilson
Compensation Summary
(Year 2023)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 4
Ratings Snapshot
Rating : A
Price Target
Institutional Ownership
OPPENHEIMERFUNDS, INC.
Shares:5.95M
Value:$131.02M
INVESCO LTD.
Shares:5.03M
Value:$110.73M
ENERGY INCOME PARTNERS, LLC
Shares:1.78M
Value:$39.12M
Summary
Showing Top 3 of 84

